mProve aims to ‘go beyond’ patient engagement with study services hub

By Melissa Fassbender

- Last updated on GMT

(Image: iStock/Pinkypills)
(Image: iStock/Pinkypills)

Related tags Clinical data acquisition Clinical trial protocol

mProve Health has partnered with Greenphire to provide payment solutions on its patient engagement app – bringing it one step closer to creating a mobile hub for all study services, says CEO.

mProve Health provides mobile technology for patient engagement and electronic clinical outcome assessments (eCOA). Greenphire is a clinical payment automation company.

Through the companies’ partnership, clinical trial participants receiving payments or reimbursements via Greenphire’s ClinCard will gain real-time access to their balance and payment history through mProve’s app, mPal.

Giving patients transparency into payment balance and transactions, along with immediate access to funds via their ClinCard, eliminates any financial hurdles that might deter a participant from fulfilling their study commitments or continuing in the trial,​” Jeff Lee, CEO at mProve Health told Outsourcing-Pharma.com. “It’s only fitting to combine these solutions in a single, mobile app.​”

mProve launched its combined patient engagement and electronic patient reported outcomes (ePRO) app in 2013. As Outsourcing-Pharma.com previously reported​, the company has been growing in response to demand for patient-operated mobile technology in clinical trials.

The vision for our mPal solution is to go beyond standard patient engagement and ePRO, to create a mobile hub that includes all study services (i.e. transportation, lab courier, etc.) in a single solution​,” explained Lee.

Adding patient payment information via the integration with Greenphire’s ClinCard brings us one step closer to offering patients all the services they could need for any trial,​” he said.

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us

Products

View more

Webinars